Cholestatic hepatitis induced by flutamida. Presentation of a case;Hepatitis colestásica inducida por flutamida. Presentación de un caso

Revista Colombiana de Gastroenterologia

Volumn 24, Issue 4, 2009, Pages 408-412

  del Risco, Fernando García ^a   Camargo, Juan Manuel ^a   Arrieta, Harold España ^a  

^a UNIVERSIDAD DE CARTAGENA   (Colombia)

Author keywords

Cholestatic hepatitis; Flutamide; Hepatotoxicity; Prostate cancer

Indexed keywords

EID: 77952871107     PISSN: 01209957     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Bloomer JR, Goodman ZD, Ishak KG. Drug-induced liver injury pathology. In: clinical and pathological correlations in liver disease: Approaching the next millennium; American Association for the Study of Liver Diseases. Postgraduate Course; 1998: 236-239.
2. Sgro C, Clinard F, Ouazir K, Chanay H, Allard C, Guilleminet C, et al. Incidence of drug-induced hepatic injuries: A French population-based study. Hepatology 2002; 36: 451-459.
3. Andrade RJ, Lucena MI, Fernández MC, Suárez F, Montero JL, Fraga E, y col. Fulminant liver failure associated with flutamide therapy for hirsutism. Lancet 1999; 353: 983.
4. Azziz, R. The evaluation and management of hirsutism. Obstet Gynecol 2003; 101: 995-998.
5. García-Cortés M, Andrade RJ, Lucena MI, Sánchez-Martínez H, Fernández MC, Ferrer T, y col. Hepatotoxicidad por flutamida: análisis retrospectivo de una serie. Rev Esp Enferm Dig 2001; 93: 424-427.
6. Lee HW, Chung JP, Lee KS, Kim KC, Lee KS, Chon CY, et al. A case of Flutamide-Induced Acute Cholestatic Hepatitis. Yonsei Med J 1996; 37(3): 225-229.
7. Caballería E, Aragó JV, Sanchís A. Hepatotoxicidad por flutamida. Med Clin (Barc) 1994; 102: 434-438.
8. Takashima E, Iguchi K, Usui S, Yamamoto H, Hirano K. Metabolite Profi les of Flutamide in Serum from Patients with Flutamide-Induced Hepatic Dysfunction. Biol Pharm Bull 2003; 26(10): 1455-1460.
9. Brodgen RN, Clissold SP. Flutamide: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in advanced prostatic cancer. Drugs Aging 1991; 1: 104.
10. Gomez JL, Dupont A, Cusan L, Tremblay M, Suburu R, Lemay M, et al. Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients. Am J Med 1992; 92: 465-470.
11. Wysowski DK, Fourcroy JL. Flutamide hepatotoxicity. J Urol 1996; 155: 209-214.
12. Wysowski DK, Freiman JP, Tourtelot JB, Horton ML. Fatal and nonfatal hepatotoxicity associated with flutamide. Ann Intern Med 1993; 118: 860-864.
13. Fernández CM, Morano LE, Montes J, Fachal C. Fallo hepático fulminante con evolución fatal inducido por flutamida. Med Clin (Barc) 1997; 108: 237-238.
14. Robson M, Dawson N. How is androgen-dependent metastatic prostate cancer best treated? Hematol Oncol Clin North Am 1996; 10: 727-738.
15. Labrie F. Mechanism of action and pure antiandrogenic properties of flutamide. Cancer 1993; 72(supl. 12): 3816-3824.
16. Cetin M, Demirci D, Unal A, Altinbaş M, Güven M, Unlühizarci K. Frequency of flutamide induced hepatotoxicity in patients with prostate carcinoma. Hum Exp Toxicol 1999; 18: 137-140.
17. Rosenthal SA, Linstadt DE, Leibenhaut MH, Andras EJ, Brooks CP, Stickney DR, et al. Flutamide associated liver toxicity during treatment with total androgen suppression and radiation therapy for prostate cancer. Radiology 1996; 199: 451-455.
18. Knowles SR, Uetrecht J, Shear NH. Idiosyncratic drug reactions: The reactive metabolite syndromes. Lancet 2000; 356: 1587-1591.
19. Navarro VJ, Senior JR. Drug-related hepatotoxicity. N Engl J Med 2006; 354: 731-739.
20. Benichou C. Criteria of drug-induced liver disorders. Report of an international consensus meeting. J Hepatol 1990; 11: 272-274.
21. Kaplowitz N. Drug-induced liver injury. Clin Infect Dis 2004; 38(Supl 2): S44-S48.
22. Pu YS, Liu CM, Kao JH, Chen J, Lai MK. Antiandrogen hepatotoxicity in patients with chronic viral hepatitis. Eur Urol 1999; 36: 293-297.
23. Dourakis SP, Alexopoulou AA, Hadziyannis SJ. Fulminant hepatitis aft er flutamide treatment. J Hepatol 1994; 20 (3): 350-3.
24. Aizawa Y, Ikemoto I, Kishimoto K, Wada T, Yamazaki H, Ohishi Y, Kiyota H, et al. Flutamide-induced hepatic dysfunction in relation to steady-state plasma concentrations of flutamide and its metabolites. Mol Cell Biochem 2003; 252(1-2): 149-156.